Medulloblastoma
Showing NaN - NaN of 10
Neuroblastoma, Medulloblastoma Trial in United States (Nifurtimox, Cyclophosphamide, Topotecan)
Completed
- Neuroblastoma
- Medulloblastoma
- Nifurtimox
- +2 more
-
San Diego, California
- +14 more
Dec 28, 2022
Neuroblastoma, Medulloblastoma Trial in United States (TPI 287)
Terminated
- Neuroblastoma
- Medulloblastoma
- TPI 287
-
San Diego, California
- +7 more
Apr 20, 2022
Medulloblastoma, CNS Embryonal Tumors Trial in Canada, New Zealand, United States (Induction, Single Cycle Intensive
Recruiting
- Medulloblastoma
- Central Nervous System Embryonal Tumors
- Induction
- +2 more
-
Birmingham, Alabama
- +61 more
Feb 16, 2022
Desmoplastic/Nodular Medulloblastoma, Medulloblastoma, Medulloblastoma With Extensive Nodularity Trial in Worldwide
Active, not recruiting
- Desmoplastic/Nodular Medulloblastoma
- +4 more
- Carboplatin
- +6 more
-
Birmingham, Alabama
- +172 more
Jan 4, 2022
Anaplastic Medulloblastoma, Medulloblastoma Trial in Worldwide (drug, biological, other, radiation)
Active, not recruiting
- Anaplastic Medulloblastoma
- Medulloblastoma
- Carboplatin
- +8 more
-
Birmingham, Alabama
- +195 more
Jan 4, 2022
